Efavirenz Itraconazole 476

Clinical Bottom Line
Minimal data to guide interaction: risks likely to outweigh benefits
Drug 1
Drug 1 dose
600 mg x 14 days
Drug 1 effect

No significant change

Drug 2
Drug 2 dose
200 mg Q12H x 28 days
Drug 2 effect

Itraconazole AUC decreased 39%; Cmax decreased 37%; Cmin decreased 44%; Hydroxyitraconazole AUC decreased 37%; Cmax decreased 35%; Cmin decreased 43%

Clinical Effects

Decreased itraconazole effects

Management

Avoid combination and use alternative agents

Import ID
476